Company Filing History:
Years Active: 2010-2014
Title: Innovations of Eigen Peralta in Small Non-Coding RNA Modulation
Introduction
Eigen Peralta is an accomplished inventor based in Chula Vista, CA (US). He has made significant contributions to the field of molecular biology, particularly in the modulation of small non-coding RNAs. With a total of 2 patents, his work has the potential to impact the diagnosis and treatment of various diseases.
Latest Patents
Eigen Peralta's latest patents include a method of inhibiting miR-33 using a modified oligonucleotide. This patent provides compounds, compositions, and methods for modulating the expression and function of small non-coding RNAs. The compositions comprise oligomeric compounds targeted to small non-coding RNAs. Additionally, methods of using these compounds for modulation of small non-coding RNAs, as well as downstream targets of these RNAs, are also provided for the diagnosis and treatment of diseases associated with small non-coding RNAs. Another patent focuses on oligomeric compounds and compositions for use in the modulation of small non-coding RNAs, further emphasizing the importance of this research area.
Career Highlights
Eigen Peralta is currently associated with Regulus Therapeutics Inc., where he continues to advance his research in the field. His innovative approaches have garnered attention and recognition within the scientific community.
Collaborations
Eigen has collaborated with notable colleagues, including Christine Esau and Bridget Lollo, who share his passion for advancing research in small non-coding RNAs.
Conclusion
Eigen Peralta's contributions to the field of molecular biology through his patents and collaborations highlight his role as a key innovator in the modulation of small non-coding RNAs. His work promises to pave the way for new therapeutic strategies in the treatment of diseases.